ReportGem ReportGem

U.S. COMPANY FILING

Edwards Lifesciences Corp — Form 8-K filed 2026-02-10

Filed: 2026-02-10Company: Edwards Lifesciences CorpTicker: EWExchange: NYSEForm: 8-KReport period: 2026-02-10SEC accession: 0001099800-26-000006Event: earningsMateriality: 70

Filing text preview

Edwards Lifesciences Corporation filed a Form 8-K on February 10, 2026, announcing its fourth quarter 2025 financial results via a press release furnished as Exhibit 99.1. The information is furnished under Item 2.02 and is not deemed filed. The report was signed by CFO Scott B. Ullem.

This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.

Open filing record